Charles River Laboratories International, Inc. (CRL)
NYSE · Healthcare
Charles River Laboratories International, Inc. Net Income 2020–2025
Charles River Laboratories International, Inc. annual/quarterly net income history and growth rate from 2020 to 2026. Net income is the total earnings of a company after all expenses, including taxes and interest, have been deducted from total revenues.
- Charles River Laboratories International, Inc. net income for the quarter ending March 31, 2026 was -14.8 M, a 157.20% decrease year-over-year.
- Charles River Laboratories International, Inc. net income for the twelve months ending March 31, 2026 was -182.8 M.
- Charles River Laboratories International, Inc. annual net income for 2025 was -142.2 M, a 662.11% decrease from 2024.
- Charles River Laboratories International, Inc. annual net income for 2024 was 25.3 M, a 94.74% decrease from 2023.
- Charles River Laboratories International, Inc. annual net income for 2023 was 480.4 M, a 2.48% decrease from 2022.
- Charles River Laboratories International, Inc. annual net income for 2022 was 492.6 M.
Net Income
ANNUAL · $B
QUARTERLY · $B
YEAR-OVER-YEAR GROWTH · %
Charles River Laboratories International, Inc. Net Income — FAQ
Charles River Laboratories International, Inc. (CRL) net income over the last 6 years — annual and quarterly figures with year-over-year growth and charts.
What is Charles River Laboratories International, Inc.'s net income?
Charles River Laboratories International, Inc. (CRL) reported net income of -$142M for fiscal 2025.
Where can I see CRL's net income history?
The chart and table above show Charles River Laboratories International, Inc.'s net income by year and by quarter, including the growth rate.